Protego Biopharma: Valuation, Funding & Investors
Protego Biopharma is a San Diego-based biotech company focused on developing small-molecule drugs that target protein misfolding pathways. By reprogramming cellular processes to restore proper protein function, Protego aims to treat rare and systemic diseases with precision and improved patient outcomes.
Leadership & Board
- Current Number of Employees
- 31
- Current LinkedIn Followers
- 5,090
Latest Estimated Valuation
- Total Amount Raised
- $130M
- Total Funding Rounds
- 1
- Latest Funding Amount
- $130M
- Latest Funding Round
- Series B
Company Momentum
PositiveProtego Biopharma LinkedIn following is increasing, signaling rising market interest, while its workforce is growing, indicating business expansion.
Employee Trend
Protego Biopharma had 31 employees as of November 2, 2026. The number of employees increased by 0 (0.00%) week-over-week.
Social Trend
Protego Biopharma had 5,090 followers as of November 2, 2026. The number of followers increased by 96 (1.92%) week-over-week.
Funding Round
| Funding Date | Funding Round | Amount Raised | Post-Money Valuation |
|---|---|---|---|
| Dec 01, 2025 | Series B | $130.00M | ― |
Investors
| Investor Name | Funding Round |
|---|---|
| Omega Funds | Series B |
| Lightspeed Venture Partners | Series B |
| Forbion | Series B |
| Digitalis Ventures | Series B |
| Droia Ventures | Series B |
| Novartis Venture Fund | Series B |
| YK Bioventures | Series B |
| Vida Ventures | Series B |
Similar Companies
A snapshot of private companies similar to Protego Biopharma, helping you discover and navigate related company profiles.
Related News and Analysis
